You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Neurological conditions
  5. Headaches

Botulinum toxin type A for the prevention of headaches in adults with chronic migraine

  • Technology appraisal guidance
  • Reference number: TA260
  • Published:  27 June 2012
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Migraine (chronic) - botulinum toxin type A: additional evidence submitted by Allergan

  • Migraine (chronic) - botulinum toxin type A: Australian report on botox for chronic migraine

  • Migraine (chronic) - botulinum toxin type A: appendix 4


This page was last updated: 08 May 2012

Back to top